These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28552522)

  • 1. Lysophosphatidylcholine elicits intracellular calcium signaling in a GPR55-dependent manner.
    Drzazga A; Sowinska A; Krzeminska A; Rytczak P; Koziolkiewicz M; Gendaszewska-Darmach E
    Biochem Biophys Res Commun; 2017 Jul; 489(2):242-247. PubMed ID: 28552522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidylcholine and its phosphorothioate analogues potentiate insulin secretion via GPR40 (FFAR1), GPR55 and GPR119 receptors in a different manner.
    Drzazga A; Kristinsson H; Sałaga M; Zatorski H; Koziołkiewicz M; Gendaszewska-Darmach E; Bergsten P
    Mol Cell Endocrinol; 2018 Sep; 472():117-125. PubMed ID: 29225068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-OMe-lysophosphatidylcholine analogues are GPR119 ligands and activate insulin secretion from βTC-3 pancreatic cells: Evaluation of structure-dependent biological activity.
    Drzazga A; Sowińska A; Krzemińska A; Okruszek A; Paneth P; Koziołkiewicz M; Gendaszewska-Darmach E
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jan; 1863(1):91-103. PubMed ID: 29079451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPR55 agonist lysophosphatidylinositol and lysophosphatidylcholine inhibit endothelial cell hyperpolarization via GPR-independent suppression of Na
    Bondarenko AI; Montecucco F; Panasiuk O; Sagach V; Sidoryak N; Brandt KJ; Mach F
    Vascul Pharmacol; 2017 Feb; 89():39-48. PubMed ID: 28064014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoprenoid Derivatives of Lysophosphatidylcholines Enhance Insulin and GLP-1 Secretion through Lipid-Binding GPCRs.
    Drzazga A; Kamińska D; Gliszczyńska A; Gendaszewska-Darmach E
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophosphatidylcholine and lysophosphatidylinosiol--novel promissing signaling molecules and their possible therapeutic activity.
    Drzazga A; Sowińska A; Koziołkiewicz M
    Acta Pol Pharm; 2014; 71(6):887-99. PubMed ID: 25745761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different mechanisms of lysophosphatidylcholine-induced Ca(2+) mobilization in N2a mouse and SH-SY5Y human neuroblastoma cells.
    Li XH; Long DX; Li W; Wu YJ
    Neurosci Lett; 2007 Aug; 424(1):22-6. PubMed ID: 17703881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginseng Gintonin Contains Ligands for GPR40 and GPR55.
    Cho YJ; Choi SH; Lee R; Hwang H; Rhim H; Cho IH; Kim HC; Lee JI; Hwang SH; Nah SY
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32121640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of lysophosphatidylcholine-induced Ca2+ response in human neuroblastoma SH-SY5Y cells.
    Li XH; Wu YJ
    Life Sci; 2007 Feb; 80(9):886-92. PubMed ID: 17157326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligands.
    Kotsikorou E; Madrigal KE; Hurst DP; Sharir H; Lynch DL; Heynen-Genel S; Milan LB; Chung TD; Seltzman HH; Bai Y; Caron MG; Barak L; Abood ME; Reggio PH
    Biochemistry; 2011 Jun; 50(25):5633-47. PubMed ID: 21534610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-Activity Relationship of the GPR55 Antagonist, CID16020046.
    Brown AJ; Castellano-Pellicena I; Haslam CP; Nichols PL; Dowell SJ
    Pharmacology; 2018; 102(5-6):324-331. PubMed ID: 30296786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent and selective N-(4-sulfamoylphenyl)thiourea-based GPR55 agonists.
    Yrjölä S; Parkkari T; Navia-Paldanius D; Laitinen T; Kaczor AA; Kokkola T; Adusei-Mensah F; Savinainen JR; Laitinen JT; Poso A; Alexander A; Penman J; Stott L; Anskat M; Irving AJ; Nevalainen TJ
    Eur J Med Chem; 2016 Jan; 107():119-32. PubMed ID: 26575458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55.
    Yamashita A; Oka S; Tanikawa T; Hayashi Y; Nemoto-Sasaki Y; Sugiura T
    Prostaglandins Other Lipid Mediat; 2013 Dec; 107():103-16. PubMed ID: 23714700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Crucial Amino Acid Residues Involved in Agonist Signaling at the GPR55 Receptor.
    Lingerfelt MA; Zhao P; Sharir HP; Hurst DP; Reggio PH; Abood ME
    Biochemistry; 2017 Jan; 56(3):473-486. PubMed ID: 28005346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysophosphatidylcholine Containing Anisic Acid Is Able to Stimulate Insulin Secretion Targeting G Protein Coupled Receptors.
    Drzazga A; Okulus M; Rychlicka M; Biegała Ł; Gliszczyńska A; Gendaszewska-Darmach E
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32331428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances Towards The Discovery of GPR55 Ligands.
    Morales P; Jagerovic N
    Curr Med Chem; 2016; 23(20):2087-100. PubMed ID: 27109575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of GPR55 as a lysophosphatidylinositol receptor.
    Oka S; Nakajima K; Yamashita A; Kishimoto S; Sugiura T
    Biochem Biophys Res Commun; 2007 Nov; 362(4):928-34. PubMed ID: 17765871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple actions of lysophosphatidylcholine in human Jurkat T cells.
    Im YJ; Lee YK; Chung HY; Im DS
    Acta Pharmacol Sin; 2006 Jun; 27(6):700-7. PubMed ID: 16723088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation.
    Henstridge CM; Balenga NA; Ford LA; Ross RA; Waldhoer M; Irving AJ
    FASEB J; 2009 Jan; 23(1):183-93. PubMed ID: 18757503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential activation of cultured neonatal cardiomyocytes by plasmalemmal versus intracellular G protein-coupled receptor 55.
    Yu J; Deliu E; Zhang XQ; Hoffman NE; Carter RL; Grisanti LA; Brailoiu GC; Madesh M; Cheung JY; Force T; Abood ME; Koch WJ; Tilley DG; Brailoiu E
    J Biol Chem; 2013 Aug; 288(31):22481-92. PubMed ID: 23814062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.